In these groups , the compliance rates with regard to QoL assessment were 74.5 % and 73.0 % , respectively , after three chemotherapy cycles ; 86.8 % and 86.9 % , respectively , after six chemotherapy cycles ; and 74.2 % and 71.6 % , respectively , at 12 months after randomization .